Unlock more of your clinical value with Transpire Bio's inhalation technologies
We partner with leading pharmaceutical companies who are looking to accelerate innovation and unlock clinical value by leveraging the power of inhaled therapeutics.
Unlock more of your clinical value with Transpire Bio's inhalation technologies
We partner with leading pharmaceutical companies who are looking to accelerate innovation and unlock clinical value by leveraging the power of inhaled therapeutics.
Inhaled therapeutics have the potential to help:
Reduce side effects by bypassing the GI tract
Improve bioavailability, a common cause of clinical trial failures
Better target the delivery of therapeutics for lung diseases
Mitigate liver toxicity issues, a common cause of clinical drug failures
Improve benefit-to-risk ratios for both local and systemic drugs
We offer multiple partnership avenues at different points in the development roadmap:
Co-development partnerships – Partner therapies
Strategic partnerships to develop innovative therapies by applying Transpire Bio’s inhalation technology platforms to a pharmaceutical partner’s existing novel or in-market therapeutics.
Co-Development partnerships – Transpire Bio therapies
Strategic partnerships and licensing agreements to bring Transpire Bio’s early-stage and mid-stage therapeutic assets to market by leveraging a pharmaceutical partner’s late-stage clinical, regulatory, and commercialization capabilities.
Commercialization partnerships – Complex generics
Licensing agreements for the commercialization of one of Transpire Bio’s early-entry, difficult-to-replicate asthma/COPD generic inhaled therapies.
Let’s discuss how Transpire Bio can partner with you to advance inhaled therapeutics
Let’s discuss how Transpire Bio can partner with you to advance inhaled therapeutics